$PAYD
PAID INC Stock $payd

$payd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000143774924010365 Filed on April 01, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$4.603M	$4.520M	$16.56M
YoY Change	11.45%	5.24%	-0.13%
Cost Of Revenue	$3.496M	$3.476M	$12.78M
YoY Change	9.73%	3.96%	-0.91%
Gross Profit	$1.108M	$1.044M	$3.786M
YoY Change	17.25%	9.74%	2.62%
Gross Profit Margin	24.06%	23.1%	22.85%
Selling, General & Admin	$1.110M	$1.006M	$4.077M
YoY Change	18.39%	13.08%	22.86%
% of Gross Profit	100.21%	96.33%	107.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$76.14K	$76.78K	$310.0K
YoY Change	-2.06%	-0.62%	-4.9%
% of Gross Profit	6.87%	7.35%	8.19%
Operating Expenses	$1.183M	$1.079M	$4.373M
YoY Change	16.9%	12.06%	20.48%
Operating Profit	-$75.53K	-$35.31K	-$587.8K
YoY Change	12.11%	197.72%	-1096.43%
Interest Expense	$0.00	$203.4K	$203.4K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$848.7K	$375.0K	$849.3K
YoY Change	578.94%	174.4%	521.44%
Pretax Income	$773.1K	$543.1K	$261.4K
YoY Change	1241.57%	335.16%	33.62%
Income Tax	$2.696K	-$92.64K	-$91.78K
% Of Pretax Income	0.35%	-17.06%	-35.11%
Net Earnings	$770.5K	$635.8K	$353.2K
YoY Change	1247.56%	-13.92%	-45.84%
Net Earnings / Revenue	16.74%	14.06%	2.13%
Basic Earnings Per Share	$0.10		$0.04
Diluted Earnings Per Share	$0.10	$0.08	$0.04
COMMON SHARES
Basic Shares Outstanding	8.065M	8.011M	7.939M
Diluted Shares Outstanding	8.072M		7.945M

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.504M	$2.052M	$2.052M
YoY Change	-20.88%	14.84%	14.84%
Cash & Equivalents	$1.504M	$2.052M	$2.052M
Short-Term Investments
Other Short-Term Assets	$225.9K	$134.1K	$134.1K
YoY Change	325.1%	-11.4%	-11.4%
Inventory
Prepaid Expenses	$225.9K	$134.1K
Receivables	$253.8K	$205.6K	$2.659M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.227M	$4.846M	$4.846M
YoY Change	54.7%	30.54%	30.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.47K	$10.68K	$24.84K
YoY Change	-39.38%	-54.54%	-46.64%
Goodwill
YoY Change
Intangibles	$2.200M	$2.423M
YoY Change	-14.7%	-9.04%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.214M	$2.447M	$2.447M
YoY Change	-14.89%	-9.68%	-9.68%
TOTAL ASSETS
Total Short-Term Assets	$6.227M	$4.846M	$4.846M
Total Long-Term Assets	$2.214M	$2.447M	$2.447M
Total Assets	$8.441M	$7.293M	$7.293M
YoY Change	27.38%	13.57%	13.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.298M	$1.482M	$1.483M
YoY Change	-16.59%	-7.94%	-7.94%
Accrued Expenses	$526.2K	$420.6K	$434.8K
YoY Change	31.2%	-2.38%	-4.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.067M	$1.933M	$1.933M
YoY Change	4.77%	-6.93%	-6.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$278.7K	$278.7K	$278.7K
YoY Change	5.1%	5.1%	5.1%
Total Long-Term Liabilities	$278.7K	$278.7K	$278.7K
YoY Change	5.1%	5.1%	5.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.067M	$1.933M	$1.933M
Total Long-Term Liabilities	$278.7K	$278.7K	$278.7K
Total Liabilities	$2.940M	$2.834M	$2.834M
YoY Change	-1.03%	-7.07%	-7.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$68.25M	-$69.32M
YoY Change	-2.38%	-0.51%
Common Stock	$8.209K	$8.154K
YoY Change	0.67%	4.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.501M	$4.459M	$4.459M
YoY Change
Total Liabilities & Shareholders Equity	$8.441M	$7.293M	$7.293M
YoY Change	27.38%	13.57%	13.57%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$770.5K	$635.8K	$353.2K
YoY Change	1247.56%	-13.92%	-45.84%
Depreciation, Depletion And Amortization	$76.14K	$76.78K	$310.0K
YoY Change	-2.06%	-0.62%	-4.9%
Cash From Operating Activities	$302.2K	$270.3K	$235.5K
YoY Change	219.5%	-21.53%	-70.61%
INVESTING ACTIVITIES
Capital Expenditures	-$50.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$50.00K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$49.95K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	$3.412K
YoY Change	-100.0%	-100.0%	-103.9%
NET CHANGE
Cash From Operating Activities	302.2K	270.3K	$235.5K
Cash From Investing Activities	-49.95K	0.000	$0.00
Cash From Financing Activities	0.000	0.000	$3.412K
Net Change In Cash	252.2K	270.3K	$265.2K
YoY Change	157.4%	-121.74%	-125.2%
FREE CASH FLOW
Cash From Operating Activities	$302.2K	$270.3K	$235.5K
Capital Expenditures	-$50.00
Free Cash Flow	$302.2K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Other Income OtherIncome	136662	usd
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001017655
CY2022Q4	payd	Investment Expiration Term InvestmentExpirationTerm	P5Y
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2023	payd	Excess Tax Benefit From Sharebased Compensation Reclassification From Operating Activities To Financing Activities ExcessTaxBenefitFromSharebasedCompensationReclassificationFromOperatingActivitiesToFinancingActivities	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4303318	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8065396
CY2023	dei	Auditor Firm AuditorFirmId	170
CY2023	dei	Auditor Name AuditorName	KMJ Corbin & Company LLP
CY2023	dei	Auditor Location AuditorLocation	Irvine, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2052421	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1787248	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	205647	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	169074	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2453425	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1604167	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	134110	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	151374	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4845603	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3711863	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10678	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23487	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2422590	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2663311	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14161	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23063	usd
CY2023Q4	us-gaap	Assets Assets	7293032	usd
CY2022Q4	us-gaap	Assets Assets	6421724	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1482498	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1610416	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	420611	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	430858	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15382	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13020	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14162	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22199	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1932653	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2076493	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	622568	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	707952	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	278704	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	265167	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2833925	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3049612	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8154474
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8010837
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7840124
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7696487
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8154	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7840	usd
CY2023Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	84576	usd
CY2022Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	82180	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	73505439	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	72800976	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	342968	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	316360	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69317190	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69670404	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	143637
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	164840	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	164840	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4459107	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3372112	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7293032	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6421724	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16564829	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16585929	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	12779181	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	12896948	usd
CY2023	us-gaap	Gross Profit GrossProfit	3785648	usd
CY2022	us-gaap	Gross Profit GrossProfit	3688981	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1984504	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1912142	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1388350	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1233549	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	703761	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	172488	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	203425	usd
CY2023	us-gaap	Other Income OtherIncome	645833	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	849258	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	136662	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	261435	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	195655	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-91779	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-456491	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	353214	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	652146	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7939210
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7770298
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7945300
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7781689
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	26608	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-273707	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	379822	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	378439	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2908678	usd
CY2022	payd	Apic Sharebased Payment Arrangement Increase For Cost Recognition Including Accrued Bonus ApicSharebasedPaymentArrangementIncreaseForCostRecognitionIncludingAccruedBonus	147488	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	106993	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19500	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	652146	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3372112	usd
CY2023	payd	Stock Issued During Period Value Accrued Bonus StockIssuedDuringPeriodValueAccruedBonus	0	usd
CY2023	payd	Stock Issued During Period Value Signing Bonus StockIssuedDuringPeriodValueSigningBonus	273438	usd
CY2023	payd	Stock Issued During Period Value Accrued Bonus And Signing Bonus StockIssuedDuringPeriodValueAccruedBonusAndSigningBonus	25000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	405323	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3412	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	353214	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4459107	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	652146	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	309972	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	325940	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	29831	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	35337	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	36845	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	270833	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	104167	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	32495	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	703761	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	172488	usd
CY2023	payd	Unrealized Gain Loss On Guarantee UnrealizedGainLossOnGuarantee	99914	usd
CY2022	payd	Unrealized Gain Loss On Guarantee UnrealizedGainLossOnGuarantee	77128	usd
CY2023	payd	Interest And Default Income Accrued On Note Receivable InterestAndDefaultIncomeAccruedOnNoteReceivable	578425	usd
CY2022	payd	Interest And Default Income Accrued On Note Receivable InterestAndDefaultIncomeAccruedOnNoteReceivable	-0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32319	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	331	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19495	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5916	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-160488	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	122833	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	7288	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-380719	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19128	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78517	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2025	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2731	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-28963	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-36501	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235516	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	801412	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1500000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3412	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19500	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	106993	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3412	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-87493	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26245	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-266358	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	265173	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1052439	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1787248	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2839687	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2052421	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1787248	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	856	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1356	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	payd	Issuance Of Common Shares In Settlement Of Accrued Expenses IssuanceOfCommonSharesInSettlementOfAccruedExpenses	82180	usd
CY2022	payd	Issuance Of Common Shares In Settlement Of Accrued Expenses IssuanceOfCommonSharesInSettlementOfAccruedExpenses	0	usd
CY2023	payd	Adjustment To Operating Lease Right Of Use Assets And Operating Lease Obligations Due To Lease Amendment AdjustmentToOperatingLeaseRightOfUseAssetsAndOperatingLeaseObligationsDueToLeaseAmendment	20620	usd
CY2022	payd	Adjustment To Operating Lease Right Of Use Assets And Operating Lease Obligations Due To Lease Amendment AdjustmentToOperatingLeaseRightOfUseAssetsAndOperatingLeaseObligationsDueToLeaseAmendment	0	usd
CY2022Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	82180	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	856	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2052421	usd
CY2023Q4	payd	Net Working Capital NetWorkingCapital	2912950	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-587823	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235516	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69317190	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	58993	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1356	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by the Company’s management include, but are not limited to, the collectability of accounts and note receivable, the recoverability of long-lived assets, the valuation of deferred tax assets and liabilities, renewal periods and discount rates for leases and the valuation of share-based transactions. Actual results could materially differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Concentration of Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company maintains cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to USD $250,000 and the Canadian Depositors Insurance Corporation (“CDIC”) up to CAD $100,000. At December 31, 2023, the Company had amounts that exceeded the CDIC insurance limits but none that were in excess of the FDIC insurance limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to these deposits.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company extends credit based on an evaluation of the customer's financial condition, generally without requiring collateral. Exposure to losses on accounts receivable is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. Although the Company expects to collect amounts due, actual collections may differ from the estimated amounts. During the years ended December 31, 2023 and 2022, the Company recorded a bad debt expense of $0 and $36,845, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the years ended December 31, 2023 and 2022, <span style="-sec-ix-hidden:c404">no</span> revenues from any one individual customer accounted for more than 10% of the total revenues. As of December 31, 2023, there was <span style="-sec-ix-hidden:c405">one</span> customer that accounted for more than 10% of the accounts receivable balance and for the year ended December 31, 2022 there were no customers that accounted for more than 10% of the accounts receivable balance.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36845	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	85000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	13536	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-364879	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	263565	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	247549	usd
CY2023Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	84576	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	353214	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	652146	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7939210
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7770298
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6090
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11391
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7945300
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7781689
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16564829	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16585929	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-587823	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the segment reporting for the years ended 2023 and 2022, to consolidate revenue reporting for smaller segments of the Company.</p>
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	205647	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	169074	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15382	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13020	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13020	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	11154	usd
CY2022Q4	payd	Investment Expiration Term InvestmentExpirationTerm	P5Y
CY2022Q4	payd	Investment Purchase Price Percentage Of Original Principal InvestmentPurchasePricePercentageOfOriginalPrincipal	0.50	pure
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	606974	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	603410	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	596296	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	579923	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10678	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23487	usd
CY2023	us-gaap	Depreciation Depreciation	13116	usd
CY2022	us-gaap	Depreciation Depreciation	14900	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6169066	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3746476	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2422590	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6037021	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3373710	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2663311	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	296856	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	311809	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	302166	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	302166	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	302166	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	302166	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	302166	usd
CY2023Q4	payd	Finitelived Intangible Asset Expected Amortization Total FinitelivedIntangibleAssetExpectedAmortizationTotal	1510830	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.87	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0373	pure
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14392	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-363523	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	238161	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	195803	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3685	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	40075	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	40075	usd
CY2023Q4	payd	Accrued Cost Of Revenues Current AccruedCostOfRevenuesCurrent	119737	usd
CY2022Q4	payd	Accrued Cost Of Revenues Current AccruedCostOfRevenuesCurrent	168657	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	22228	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	22228	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	410	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	410	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	420611	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	430858	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	13021
CY2022Q2	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.92
CY2022Q2	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	25000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.975
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19500	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3500
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.975
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3412	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	452000
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y29D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	444566
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	371000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.07
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	85000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.75
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	500
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.98
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3500
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.98
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	452000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.84
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y29D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7363	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	444566
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.85
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y21D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7363	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2228	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	25300	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	649079	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-77704	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-387644	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	273359	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	261435	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	195655	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-106173	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-92968	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-106173	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-92968	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-91779	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-456491	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1887	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0562	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0649	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.1856	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.081	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0	pure
CY2023	payd	Effective Income Tax Rate Reconciliation Attributes Expiration Percent EffectiveIncomeTaxRateReconciliationAttributesExpirationPercent	0.0133	pure
CY2022	payd	Effective Income Tax Rate Reconciliation Attributes Expiration Percent EffectiveIncomeTaxRateReconciliationAttributesExpirationPercent	0.1706	pure
CY2023	payd	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	-0.0113	pure
CY2022	payd	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	-2.5775	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.1376	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.3065	pure
CY2023	payd	Effective Income Tax Rate Reconciliation Net Operating Loss Adjustments Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentsPercent	-0.6074	pure
CY2022	payd	Effective Income Tax Rate Reconciliation Net Operating Loss Adjustments Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentsPercent	2.9528	pure
CY2023	payd	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefit Percent EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitPercent	-0.0965	pure
CY2022	payd	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefit Percent EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitPercent	3.6172	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Percent EffectiveIncomeTaxRateReconciliationGiltiPercent	0.6912	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Gilti Percent EffectiveIncomeTaxRateReconciliationGiltiPercent	1.565	pure
CY2023	payd	Effective Income Tax Rate Reconciliation Interest And Penalties Percent EffectiveIncomeTaxRateReconciliationInterestAndPenaltiesPercent	0	pure
CY2022	payd	Effective Income Tax Rate Reconciliation Interest And Penalties Percent EffectiveIncomeTaxRateReconciliationInterestAndPenaltiesPercent	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.8623	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-8.8241	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.3528	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-2.3377	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7267720	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7495858	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	31340	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	31340	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	223680	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	196700	usd
CY2023Q4	payd	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Lease Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiabilities	3753	usd
CY2022Q4	payd	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Lease Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiabilities	5883	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	14213	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	14695	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	96	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	96	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7540802	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7744572	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	606765	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	668359	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	3753	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6112	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7552852	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7778053	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	622568	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	707952	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-225000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1727000	usd
CY2023Q4	payd	Deferred Tax Assets Valuation Allowance Percent DeferredTaxAssetsValuationAllowancePercent	1	pure
CY2022Q4	payd	Deferred Tax Assets Valuation Allowance Percent DeferredTaxAssetsValuationAllowancePercent	1	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	691675000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	15957000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	691675000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	707632000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	691675000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	733798	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	29290	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	39324	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	30896	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	38355	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14161	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23063	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14162	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22199	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	14162	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	22199	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	14644	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14644	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	482	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	14162	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14162	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	54559

Files In Submission

Name	View Source	Status
0001437749-24-010365-index-headers.html	Edgar Link	pending
0001437749-24-010365-index.html	Edgar Link	pending
0001437749-24-010365.txt	Edgar Link	pending
0001437749-24-010365-xbrl.zip	Edgar Link	pending
ex_644116.htm	Edgar Link	pending
ex_644117.htm	Edgar Link	pending
ex_648130.htm	Edgar Link	pending
ex_648131.htm	Edgar Link	pending
ex_648132.htm	Edgar Link	pending
ex_648412.htm	Edgar Link	pending
ex_648413.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
paid.jpg	Edgar Link	pending
payd-20231231.xsd	Edgar Link	pending
payd20231231_10k.htm	Edgar Link	pending
payd-20231231_cal.xml	Edgar Link	unprocessable
payd-20231231_lab.xml	Edgar Link	unprocessable
payd-20231231_def.xml	Edgar Link	unprocessable
payd20231231_10k_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
z01.jpg	Edgar Link	pending
z02.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
payd-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PAYD
PAID INC Stock $payd

2024 Q2 Form 10-K Financial Statement

#000143774924010365 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAYD PAID INC Stock $payd

2024 Q2 Form 10-K Financial Statement

#000143774924010365 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAYD
PAID INC Stock $payd